About
Dr. Lucian Iancovici has served as an Achieve Life Sciences director since 2026 and became Chairman of the Board effective June 8, 2026; he also serves on the Compensation Committee. He is a Partner of TPG, a global alternative asset manager, where he has worked since January 2018, and previously headed the Qualcomm Life Fund and was a general partner at dRx Capital, a Novartis-Qualcomm joint venture. Dr. Iancovici serves on the boards of Sionna Therapeutics (since 2019) and Rallybio Corporation (since 2020) and several private companies. He is a board-certified internal medicine physician who trained at Columbia University Medical Center and received his B.A. in economics and his M.D. from Tufts University.
Roles
External Roles
Also at Achieve Life Sciences, Inc.
See how Top Bucket AI works for your firm
Request DemoStay ahead of private markets
Research and market intelligence for private-markets professionals.
You're subscribed.
Thanks for signing up.